Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China flag China · Delayed Price · Currency is CNY
5.07
-0.12 (-2.31%)
Sep 10, 2026, 3:04 PM CST

SHE:300239 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
789.22743.59850.21970.41937.89609.82
Other Revenue
1.721.7234.724.15.512.34
790.94745.31884.93974.51943.4612.17
Revenue Growth
-2.32%-15.78%-9.19%3.30%54.11%36.39%
Cost of Revenue
635.31587.36687.88728.53712.28515.98
Gross Profit
155.64157.95197.06245.98231.1296.19
Selling, General & Admin
69.7169.2167.9669.7567.8140.1
Research & Development
23.8525.4827.3626.125.8312.98
Other Operating Expenses
9.638.64.9212.5812.529.23
Operating Expenses
104.05104.1499.82110.21106.4762.34
Operating Income
51.5853.8197.23135.77124.6533.85
Interest Expense
-4.01-4.01-2.56-5.14-7.63-4.78
Interest & Investment Income
2.782.787.116.374.842.88
Currency Exchange Gain (Loss)
0.120.121.030.260.7-0.03
Other Non Operating Income (Expenses)
0.89-0.29-0.18-0.17-0.211.44
EBT Excluding Unusual Items
51.3652.4102.63137.08122.3533.37
Gain (Loss) on Sale of Investments
-2.27-2.86-3.74-4.33-1.91-2.53
Gain (Loss) on Sale of Assets
0.02-0.09-0.280.080.140.09
Asset Writedown
-0.09-0.27-0.88-0.86-0.42-0.6
Other Unusual Items
12.1912.197.7912.4711.2511.21
Pretax Income
61.7761.92105.63144.49131.6541.54
Income Tax Expense
77.5814.3717.1216.215.72
Earnings From Continuing Operations
54.7754.3491.26127.37115.4435.82
Minority Interest in Earnings
00-5.28-7.49-60.66
Net Income
54.7754.3485.98119.89109.4436.48
Net Income to Common
54.7754.3485.98119.89109.4436.48
Net Income Growth
-23.51%-36.80%-28.28%9.55%199.96%97.74%
Shares Outstanding (Basic)
589586594593593564
Shares Outstanding (Diluted)
629626647612593564
Shares Change
-1.96%-3.24%5.72%3.12%5.25%7.89%
EPS (Basic)
0.090.090.140.200.180.06
EPS (Diluted)
0.090.090.130.200.180.06
EPS Growth
-21.98%-34.69%-32.16%6.24%185.01%83.29%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-28.6426.65-8.0467.1586.760.15
Free Cash Flow Per Share
-0.050.04-0.010.110.15-
Dividend Per Share
0.0120.0120.0250.0220.0260.006
Dividend Growth
-52.00%-52.00%13.64%-15.38%333.33%-
Gross Margin
19.68%21.19%22.27%25.24%24.50%15.71%
Operating Margin
6.52%7.22%10.99%13.93%13.21%5.53%
Profit Margin
6.93%7.29%9.72%12.30%11.60%5.96%
Free Cash Flow Margin
-3.62%3.58%-0.91%6.89%9.20%0.02%
EBITDA
150.03150.97183.67217.73210.1689.17
EBITDA Margin
18.97%20.26%20.76%22.34%22.28%14.57%
D&A For EBITDA
98.4497.1686.4481.9685.5255.32
EBIT
51.5853.8197.23135.77124.6533.85
EBIT Margin
6.52%7.22%10.99%13.93%13.21%5.53%
Effective Tax Rate
11.33%12.25%13.60%11.85%12.31%13.76%
Revenue as Reported
745.31745.31884.93974.51943.4612.17
Advertising Expenses
-0.850.571.121.080.81